Astellas Pharma and NovaMed Pharmaceuticals are two companies that have collaborated to develop and market a range of medications used to treat various diseases and conditions. These medications are manufactured using the latest scientific knowledge and technology, and are known for their effectiveness and safety. Uses One of the most widely prescribed medications in the collaboration is Astellas' Myrbetriq (mirabegron). This medication is used to treat symptoms of overactive bladder in adults, such as frequent urination, urgency, and urge incontinence. Another commonly prescribed medication is Astellas' Xtandi (enzalutamide), which is used to treat advanced prostate cancer in men. This medication works by blocking the action of testosterone, which can promote the growth of prostate cancer cells. Dosage The dosage of these medications may vary depending on the individual's age, weight, and medical history. It is important to follow the dosage instructions given by the healthcare provider or pharmacist to avoid any adverse effects. For Myrbetriq, the typical dosage is one 25 mg tablet taken once daily. If necessary, the dose may be increased to 50 mg once daily. It is recommended to take the medication with water and without food. For Xtandi, the recommended dose is 160 mg (four 40 mg capsules) taken once daily. The capsules should be swallowed whole with water and should not be opened, crushed, or chewed. Side Effects Like all medications, Astellas and NovaMed medications may cause side effects. Common side effects of Myrbetriq include headache, urinary tract infection, and diarrhea. Less common but more serious side effects may include high blood pressure, angioedema (swelling of the face, lips, tongue, or throat), and urinary retention. Xtandi may cause some common side effects, such as fatigue, hot flashes, and back pain. Serious side effects may include seizures, heart attack, and stroke. Interactions Certain medications, supplements, and foods may interact with Astellas and NovaMed medications, potentially causing serious side effects. It is important to inform the healthcare provider of any medications or supplements you are taking before starting treatment with these medications. For example, Myrbetriq may interact with certain medications used to treat high blood pressure, resulting in dangerously low blood pressure. It may also interact with medications used to treat liver disease. Xtandi may interact with blood-thinning medications such as warfarin, increasing the risk of bleeding. It may also interact with medications used to lower cholesterol levels, resulting in elevated liver enzyme levels. Generic Both Myrbetriq and Xtandi are currently available only in their brand-name forms and do not yet have generic equivalents. However, generic versions may become available in the future. Demographic Myrbetriq is approved for use in adults age 18 and older who have symptoms of overactive bladder, while Xtandi is approved for use in men with advanced prostate cancer who have been previously treated with docetaxel chemotherapy. In conclusion, Astellas and NovaMed medications are effective treatments for a range of conditions. It is important to follow dosage instructions carefully and inform healthcare providers of any medications or supplements being taken to avoid potential interactions. Regular monitoring and communication with the healthcare provider can ensure the safe and effective use of these medications.